Logo image of DHH.MI

DHH SPA (DHH.MI) Stock Fundamental Analysis

Europe - BIT:DHH - IT0005203622 - Common Stock

25 EUR
+0.1 (+0.4%)
Last: 9/11/2025, 7:00:00 PM
Fundamental Rating

5

Overall DHH gets a fundamental rating of 5 out of 10. We evaluated DHH against 69 industry peers in the IT Services industry. While DHH has a great profitability rating, there are some minor concerns on its financial health. DHH shows excellent growth, but is valued quite expensive already. These ratings would make DHH suitable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

DHH had positive earnings in the past year.
DHH had a positive operating cash flow in the past year.
DHH had positive earnings in each of the past 5 years.
Each year in the past 5 years DHH had a positive operating cash flow.
DHH.MI Yearly Net Income VS EBIT VS OCF VS FCFDHH.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

1.2 Ratios

DHH has a Return On Assets of 6.23%. This is in the better half of the industry: DHH outperforms 69.57% of its industry peers.
Looking at the Return On Equity, with a value of 13.10%, DHH is in line with its industry, outperforming 53.62% of the companies in the same industry.
The Return On Invested Capital of DHH (9.59%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DHH is below the industry average of 11.46%.
The last Return On Invested Capital (9.59%) for DHH is above the 3 year average (8.73%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.23%
ROE 13.1%
ROIC 9.59%
ROA(3y)3.93%
ROA(5y)4.47%
ROE(3y)8.68%
ROE(5y)9.26%
ROIC(3y)8.73%
ROIC(5y)7.32%
DHH.MI Yearly ROA, ROE, ROICDHH.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

DHH's Profit Margin of 10.06% is amongst the best of the industry. DHH outperforms 92.75% of its industry peers.
In the last couple of years the Profit Margin of DHH has grown nicely.
DHH has a better Operating Margin (18.96%) than 95.65% of its industry peers.
DHH's Operating Margin has improved in the last couple of years.
DHH's Gross Margin of 92.68% is amongst the best of the industry. DHH outperforms 89.86% of its industry peers.
DHH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.96%
PM (TTM) 10.06%
GM 92.68%
OM growth 3Y-2.06%
OM growth 5Y54.36%
PM growth 3Y-14.91%
PM growth 5Y46.79%
GM growth 3Y-0.79%
GM growth 5Y-1.44%
DHH.MI Yearly Profit, Operating, Gross MarginsDHH.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

DHH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DHH has been increased compared to 1 year ago.
DHH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DHH has been reduced compared to a year ago.
DHH.MI Yearly Shares OutstandingDHH.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
DHH.MI Yearly Total Debt VS Total AssetsDHH.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 4.02 indicates that DHH is not in any danger for bankruptcy at the moment.
DHH has a better Altman-Z score (4.02) than 84.06% of its industry peers.
DHH has a debt to FCF ratio of 5.92. This is a neutral value as DHH would need 5.92 years to pay back of all of its debts.
The Debt to FCF ratio of DHH (5.92) is worse than 60.87% of its industry peers.
DHH has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
DHH has a Debt to Equity ratio (0.41) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 5.92
Altman-Z 4.02
ROIC/WACC0.7
WACC13.73%
DHH.MI Yearly LT Debt VS Equity VS FCFDHH.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.3 Liquidity

DHH has a Current Ratio of 1.28. This is a normal value and indicates that DHH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.28, DHH is in line with its industry, outperforming 57.97% of the companies in the same industry.
A Quick Ratio of 1.25 indicates that DHH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.25, DHH is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.25
DHH.MI Yearly Current Assets VS Current LiabilitesDHH.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

8

3. Growth

3.1 Past

DHH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.48%, which is quite impressive.
DHH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 62.49% yearly.
DHH shows a small growth in Revenue. In the last year, the Revenue has grown by 6.57%.
DHH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.65% yearly.
EPS 1Y (TTM)63.48%
EPS 3Y3.98%
EPS 5Y62.49%
EPS Q2Q%-15.07%
Revenue 1Y (TTM)6.57%
Revenue growth 3Y22.43%
Revenue growth 5Y39.65%
Sales Q2Q%4.53%

3.2 Future

The Earnings Per Share is expected to grow by 16.10% on average over the next years. This is quite good.
The Revenue is expected to grow by 11.64% on average over the next years. This is quite good.
EPS Next Y20.99%
EPS Next 2Y16.93%
EPS Next 3Y16.1%
EPS Next 5YN/A
Revenue Next Year16.03%
Revenue Next 2Y13.61%
Revenue Next 3Y11.64%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DHH.MI Yearly Revenue VS EstimatesDHH.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
DHH.MI Yearly EPS VS EstimatesDHH.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.78 indicates a quite expensive valuation of DHH.
Based on the Price/Earnings ratio, DHH is valued a bit more expensive than the industry average as 62.32% of the companies are valued more cheaply.
DHH's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.38.
Based on the Price/Forward Earnings ratio of 24.78, the valuation of DHH can be described as rather expensive.
60.87% of the companies in the same industry are cheaper than DHH, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DHH to the average of the S&P500 Index (22.86), we can say DHH is valued inline with the index average.
Industry RankSector Rank
PE 33.78
Fwd PE 24.78
DHH.MI Price Earnings VS Forward Price EarningsDHH.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than DHH, based on the Enterprise Value to EBITDA ratio.
DHH's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. DHH is more expensive than 68.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 47.17
EV/EBITDA 11.13
DHH.MI Per share dataDHH.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of DHH may justify a higher PE ratio.
DHH's earnings are expected to grow with 16.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.61
PEG (5Y)0.54
EPS Next 2Y16.93%
EPS Next 3Y16.1%

0

5. Dividend

5.1 Amount

No dividends for DHH!.
Industry RankSector Rank
Dividend Yield N/A

DHH SPA

BIT:DHH (9/11/2025, 7:00:00 PM)

25

+0.1 (+0.4%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-22 2025-05-22
Earnings (Next)09-22 2025-09-22
Inst Owners3.64%
Inst Owner ChangeN/A
Ins Owners68.88%
Ins Owner ChangeN/A
Market Cap131.00M
Analysts83.33
Price Target29.61 (18.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.7%
EPS NY rev (3m)-5.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE 33.78
Fwd PE 24.78
P/S 3.65
P/FCF 47.17
P/OCF 14.27
P/B 4.75
P/tB 10.95
EV/EBITDA 11.13
EPS(TTM)0.74
EY2.96%
EPS(NY)1.01
Fwd EY4.04%
FCF(TTM)0.53
FCFY2.12%
OCF(TTM)1.75
OCFY7.01%
SpS6.85
BVpS5.26
TBVpS2.28
PEG (NY)1.61
PEG (5Y)0.54
Profitability
Industry RankSector Rank
ROA 6.23%
ROE 13.1%
ROCE 16.31%
ROIC 9.59%
ROICexc 14.05%
ROICexgc 30.83%
OM 18.96%
PM (TTM) 10.06%
GM 92.68%
FCFM 7.74%
ROA(3y)3.93%
ROA(5y)4.47%
ROE(3y)8.68%
ROE(5y)9.26%
ROIC(3y)8.73%
ROIC(5y)7.32%
ROICexc(3y)12.23%
ROICexc(5y)10.48%
ROICexgc(3y)26.87%
ROICexgc(5y)29.48%
ROCE(3y)15.07%
ROCE(5y)12.92%
ROICexcg growth 3Y-10.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.52%
ROICexc growth 5Y53.67%
OM growth 3Y-2.06%
OM growth 5Y54.36%
PM growth 3Y-14.91%
PM growth 5Y46.79%
GM growth 3Y-0.79%
GM growth 5Y-1.44%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 5.92
Debt/EBITDA 0.94
Cap/Depr 123.07%
Cap/Sales 17.84%
Interest Coverage 250
Cash Conversion 76.45%
Profit Quality 76.95%
Current Ratio 1.28
Quick Ratio 1.25
Altman-Z 4.02
F-Score6
WACC13.73%
ROIC/WACC0.7
Cap/Depr(3y)89.93%
Cap/Depr(5y)88.5%
Cap/Sales(3y)13.53%
Cap/Sales(5y)12.57%
Profit Quality(3y)392.65%
Profit Quality(5y)477.25%
High Growth Momentum
Growth
EPS 1Y (TTM)63.48%
EPS 3Y3.98%
EPS 5Y62.49%
EPS Q2Q%-15.07%
EPS Next Y20.99%
EPS Next 2Y16.93%
EPS Next 3Y16.1%
EPS Next 5YN/A
Revenue 1Y (TTM)6.57%
Revenue growth 3Y22.43%
Revenue growth 5Y39.65%
Sales Q2Q%4.53%
Revenue Next Year16.03%
Revenue Next 2Y13.61%
Revenue Next 3Y11.64%
Revenue Next 5YN/A
EBIT growth 1Y9.7%
EBIT growth 3Y19.91%
EBIT growth 5Y115.56%
EBIT Next Year95.83%
EBIT Next 3Y32.77%
EBIT Next 5YN/A
FCF growth 1Y-33.41%
FCF growth 3Y-4.43%
FCF growth 5Y23.86%
OCF growth 1Y1.33%
OCF growth 3Y15.1%
OCF growth 5Y55.96%